Monday, October 10, 2022 8:13:45 PM
Ecomike
I take a blood thinner called Plavix for years prescribed by a cardiologist after a triple bypass. I was advised to take the mrna shot by a pcp. No mention of the side effects of the shot nor my being a good candidate for the shot. My case was not isolated. Millions of patients were not allowed informed consent for the shot. Simply get the shot order by the medical professional. I never received the shot. I did get the b4 virus and survived. In my case the cure would very possibly have led to my demise. I might have had severe uncontrolled bleeding due the the characteristics of the shot and subsequent boosters. I also have many accounts from recipients of boosters of very severe reactions affecting changes to lifestyle. I do not consider my case to be in any respect out of the ordinary!!
I take a blood thinner called Plavix for years prescribed by a cardiologist after a triple bypass. I was advised to take the mrna shot by a pcp. No mention of the side effects of the shot nor my being a good candidate for the shot. My case was not isolated. Millions of patients were not allowed informed consent for the shot. Simply get the shot order by the medical professional. I never received the shot. I did get the b4 virus and survived. In my case the cure would very possibly have led to my demise. I might have had severe uncontrolled bleeding due the the characteristics of the shot and subsequent boosters. I also have many accounts from recipients of boosters of very severe reactions affecting changes to lifestyle. I do not consider my case to be in any respect out of the ordinary!!
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
